2137 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2137 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company